$TKNO
Alpha Teknova, Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023021313 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $11.53M $9.121M $11.15M
YoY Change -1.39% -18.18% 22.79%
Cost Of Revenue $6.461M $6.698M $5.798M
YoY Change 0.28% 15.52% 43.05%
Gross Profit $5.066M $2.423M $5.349M
YoY Change -3.45% -54.7% 6.45%
Gross Profit Margin 43.95% 26.57% 47.99%
Selling, General & Admin $8.117M $9.688M $8.892M
YoY Change -15.95% 8.95% 82.74%
% of Gross Profit 160.23% 399.83% 166.24%
Research & Development $1.464M $1.395M $2.013M
YoY Change -24.11% -30.7% 187.57%
% of Gross Profit 28.9% 57.57% 37.63%
Depreciation & Amortization $1.000M $1.130M $751.0K
YoY Change 100.0% 50.47% 15.18%
% of Gross Profit 19.74% 46.64% 14.04%
Operating Expenses $12.06M $11.37M $11.19M
YoY Change 1.6% 1.58% 91.22%
Operating Profit -$6.997M -$8.946M -$5.843M
YoY Change 5.6% 53.11% 605.68%
Interest Expense -$308.0K $93.00K -$13.00K
YoY Change -1200.0% -815.38% -285.71%
% of Operating Profit
Other Income/Expense, Net -$142.0K $111.0K -$13.00K
YoY Change -607.14% -953.85% -262.5%
Pretax Income -$7.139M -$8.835M -$5.856M
YoY Change 8.2% 50.87% 614.15%
Income Tax $15.00K -$18.00K -$400.0K
% Of Pretax Income
Net Earnings -$7.154M -$8.817M -$5.497M
YoY Change 15.33% 60.4% 739.24%
Net Earnings / Revenue -62.06% -96.67% -49.31%
Basic Earnings Per Share -$0.25 -$0.31 -$0.20
Diluted Earnings Per Share -$0.25 -$0.31 -$196.1K
COMMON SHARES
Basic Shares Outstanding 28.22M 28.19M 28.04M
Diluted Shares Outstanding 28.27M 28.18M 28.03M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.71M $30.22M $76.46M
YoY Change -63.37% -60.48% 428.52%
Cash & Equivalents $23.71M $30.20M $76.46M
Short-Term Investments
Other Short-Term Assets $1.741M $2.466M $1.891M
YoY Change 2.35% 30.41% -15.84%
Inventory $12.02M $12.15M $6.426M
Prepaid Expenses
Receivables $4.572M $4.777M $5.978M
Other Receivables $22.00K $22.00K $1.188M
Total Short-Term Assets $43.11M $49.63M $91.94M
YoY Change -46.29% -46.02% 248.47%
LONG-TERM ASSETS
Property, Plant & Equipment $52.86M $53.73M $37.06M
YoY Change 11.86% 44.99% 173.98%
Goodwill $16.61M
YoY Change
Intangibles $16.98M $17.27M $18.42M
YoY Change -6.33% -6.23%
Long-Term Investments
YoY Change
Other Assets $2.030M $2.150M $396.0K
YoY Change 163.98% 442.93% 1100.0%
Total Long-Term Assets $89.44M $91.39M $92.15M
YoY Change -12.25% -0.82% 85.27%
TOTAL ASSETS
Total Short-Term Assets $43.11M $49.63M $91.94M
Total Long-Term Assets $89.44M $91.39M $92.15M
Total Assets $132.5M $141.0M $184.1M
YoY Change -27.25% -23.39% 141.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.081M $1.885M $3.028M
YoY Change -23.93% -37.75% 3.77%
Accrued Expenses $3.658M $4.758M $7.510M
YoY Change -55.66% -36.64% 136.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $22.16M
YoY Change
Total Short-Term Liabilities $28.65M $8.654M $12.64M
YoY Change 141.48% -31.51% 107.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $22.04M $11.92M
YoY Change -100.0% 84.93% 1.53%
Other Long-Term Liabilities $16.47M $17.04M $18.19M
YoY Change -6.65% -6.33% 3262.48%
Total Long-Term Liabilities $0.00 $39.08M $30.11M
YoY Change -100.0% 29.79% 145.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.65M $8.654M $12.64M
Total Long-Term Liabilities $0.00 $39.08M $30.11M
Total Liabilities $46.34M $48.93M $45.54M
YoY Change -4.9% 7.46% 88.21%
SHAREHOLDERS EQUITY
Retained Earnings -$71.00M -$63.80M -$13.04M
YoY Change 269.06% 389.45%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $86.21M $92.09M $138.5M
YoY Change
Total Liabilities & Shareholders Equity $132.5M $141.0M $184.1M
YoY Change -27.25% -23.39% 141.83%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.154M -$8.817M -$5.497M
YoY Change 15.33% 60.4% 739.24%
Depreciation, Depletion And Amortization $1.000M $1.130M $751.0K
YoY Change 100.0% 50.47% 15.18%
Cash From Operating Activities -$3.856M -$7.684M -$5.201M
YoY Change -33.95% 47.74% -316.62%
INVESTING ACTIVITIES
Capital Expenditures $2.338M $4.312M $5.917M
YoY Change -121.41% -27.13% 52.34%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.338M -$4.312M -$5.917M
YoY Change -78.59% -27.13% 287.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -180.0K -25.00K 55.00K
YoY Change -103.57% -145.45% -99.46%
NET CHANGE
Cash From Operating Activities -3.856M -7.684M -5.201M
Cash From Investing Activities -2.338M -4.312M -5.917M
Cash From Financing Activities -180.0K -25.00K 55.00K
Net Change In Cash -6.374M -12.02M -11.06M
YoY Change -45.62% 8.66% -199.21%
FREE CASH FLOW
Cash From Operating Activities -$3.856M -$7.684M -$5.201M
Capital Expenditures $2.338M $4.312M $5.917M
Free Cash Flow -$6.194M -$12.00M -$11.12M
YoY Change -221.88% 7.9% 649.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001850902
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-40538
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ALPHA TEKNOVA, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3368109
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2451 Bert Dr.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Hollister
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95023
CY2023Q1 dei City Area Code
CityAreaCode
831
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
637-1100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
TKNO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28222832
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9121000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11147000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6698000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5798000
CY2023Q1 us-gaap Gross Profit
GrossProfit
2423000
CY2022Q1 us-gaap Gross Profit
GrossProfit
5349000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1395000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2013000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2343000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1597000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7345000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7295000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
286000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
11369000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
11192000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8946000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5843000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
93000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
111000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8835000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5856000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-359000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8817000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5497000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28181457
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28181457
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28030971
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28030971
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30215000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4777000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4261000
CY2023Q1 us-gaap Inventory Net
InventoryNet
12151000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12247000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2466000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2374000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
49631000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
61140000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53733000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51577000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18237000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19736000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17270000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17556000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2150000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2252000
CY2023Q1 us-gaap Assets
Assets
141021000
CY2022Q4 us-gaap Assets
Assets
152261000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1885000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2449000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6203000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2011000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2223000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8654000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10875000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1204000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1223000
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
169000
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
191000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
22036000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
21976000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16871000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18111000
CY2023Q1 us-gaap Liabilities
Liabilities
48934000
CY2022Q4 us-gaap Liabilities
Liabilities
52376000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28190192
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28190192
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28179423
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28179423
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
155910000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154891000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63823000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55006000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
92087000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
141021000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152261000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
99885000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1010000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8817000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
92087000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
143203000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
787000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5497000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
138548000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8817000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5497000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
-144000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
-4000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1130000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
751000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1010000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
787000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-19000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-360000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
90000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46000
CY2023Q1 tkno Non Cash Lease Expense
NonCashLeaseExpense
47000
CY2022Q1 tkno Non Cash Lease Expense
NonCashLeaseExpense
106000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
518000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1319000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-240000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1028000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-271000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
547000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-102000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
216000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-386000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
237000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-670000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
762000
CY2023Q1 tkno Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
-22000
CY2022Q1 tkno Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
-20000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7684000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5201000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4312000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5917000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4312000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5917000
CY2023Q1 tkno Payment Of Offering Costs
PaymentOfOfferingCosts
-34000
CY2022Q1 tkno Payment Of Offering Costs
PaymentOfOfferingCosts
0
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
55000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12021000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11063000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87518000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30215000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76455000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
110000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2023Q1 tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
925000
CY2022Q1 tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
3884000
CY2023Q1 tkno Deferred Offering Costs Included In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
329000
CY2022Q1 tkno Deferred Offering Costs Included In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
0
CY2023Q1 tkno Debt Issuance Costs Included In Accounts Payable And Accrued Liabilities
DebtIssuanceCostsIncludedInAccountsPayableAndAccruedLiabilities
30000
CY2022Q1 tkno Debt Issuance Costs Included In Accounts Payable And Accrued Liabilities
DebtIssuanceCostsIncludedInAccountsPayableAndAccruedLiabilities
0
CY2023Q1 tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
-648000
CY2022Q1 tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
20237000
CY2023Q1 tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
-602000
CY2022Q1 tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
20507000
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="i_notes" style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 1. Nature of th</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">e Business</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alpha Teknova, Inc. (referred to herein as the Company or Teknova), produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Product offerings include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. Teknova supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions, with catalog and custom, made-to-order products.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Teknova manufactures its products at its Hollister, California headquarters and stocks inventory of raw materials, components, and finished goods at that location. The Company ships products directly from its warehouse in Hollister, California.</span></p>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11147000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33002000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32383000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8800000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5500000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63800000
CY2023Q1 tkno Working Captial
WorkingCaptial
41000000.0
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30200000
CY2023Q1 tkno Reduction In Workforce Policytext Blocks
ReductionInWorkforcePolicytextBlocks
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reduction in Workforce</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 1, 2023, the Company carried out a reduction in workforce of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> positions, aimed at reducing operating expenses. The Company incurred $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of costs in connection with the reduction in workforce related to severance pay and other termination benefits. The costs associated with the reduction in workforce were recorded in the quarter ended March 31, 2023, in general and administrative expenses.</span></p>
CY2023Q1 tkno Reduction In Workforce Of Positions
ReductionInWorkforceOfPositions
40
CY2023Q1 tkno Severance And Other Related Termination Benefits
SeveranceAndOtherRelatedTerminationBenefits
700000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9121000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11147000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9121000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8094000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8368000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
155000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
186000
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3902000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3693000
CY2023Q1 us-gaap Inventory Net
InventoryNet
12151000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12247000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5358000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4520000
CY2023Q1 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
27644000
CY2022Q4 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
27863000
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
26089000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
23714000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53733000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51577000
CY2023Q1 us-gaap Depreciation
Depreciation
800000
CY2022Q1 us-gaap Depreciation
Depreciation
500000
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
800000
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
700000
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2167000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2776000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2342000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2413000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2416000
CY2023Q1 tkno Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
11917000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24031000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5149000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18882000
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4829000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17270000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4543000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17556000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2022Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P3Y9M18D
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
862000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1148000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1148000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1148000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
45000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4351000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2429000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2796000
CY2023Q1 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
832000
CY2022Q4 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
1966000
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
51000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
198000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1446000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1243000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28030971
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6203000
CY2022Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
5000000.0
CY2021Q1 tkno Cash Received Under The Term Loan
CashReceivedUnderTheTermLoan
12000000.0
CY2022Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
40135000
CY2022Q4 tkno Cash Received Under The Term Loan2
CashReceivedUnderTheTermLoan2
5135000
CY2022Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
5000000.0
CY2022Q4 tkno Cash Received Under The Term Loan3
CashReceivedUnderTheTermLoan3
5000000.0
CY2022Q2 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
If any advance under the Term Loan was prepaid at any time, the prepayment fee was based on the amount being prepaid and an applicable percentage amount, such as 3%, 2%, or 1%, based on the date the prepayment was made after the closing date of the Term Loan.
CY2022Q2 tkno Term Loan Exit Fee Rate
TermLoanExitFeeRate
0.0500
CY2023Q1 tkno Net Revenue Requirement For The Financial Covenant
NetRevenueRequirementForTheFinancialCovenant
42500000
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
22135000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
22135000
CY2023Q1 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
234000
CY2022Q4 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
161000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-333000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-320000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
22036000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
21976000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6456000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
11068000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4611000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
22135000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1010000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
787000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.061
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8817000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5497000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28181457
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28181457
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28030971
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.20
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.20

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-021313-index-headers.html Edgar Link pending
0000950170-23-021313-index.html Edgar Link pending
0000950170-23-021313.txt Edgar Link pending
0000950170-23-021313-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tkno-20230331.htm Edgar Link pending
tkno-20230331.xsd Edgar Link pending
tkno-ex10_7.htm Edgar Link pending
tkno-ex31_1.htm Edgar Link pending
tkno-ex31_2.htm Edgar Link pending
tkno-ex32_1.htm Edgar Link pending
tkno-20230331_cal.xml Edgar Link unprocessable
tkno-20230331_def.xml Edgar Link unprocessable
tkno-20230331_lab.xml Edgar Link unprocessable
tkno-20230331_pre.xml Edgar Link unprocessable
tkno-20230331_htm.xml Edgar Link completed